Clireo eTMF Solution by Arivis
What is Clireo?
• Comprehensive Software and Service enabling the Trial Master File
• Compliant with the DIA Trial Master File Reference Model Version 3
• Assign access and maintain control of Sites, Vendors, and Auditors for content.
• Eliminate CRA need to reconcile the Investigator Site File against the Sponsor TMF.
• Part 21 CFR 11 Digital signatures allow for faster turn around time on documents.
• Ability to quickly disseminate new information to users that the information is relevant to.
• Vendors and Sites can upload documentation and data directly into Clireo.
• Unlimited storage capacity assures that all documentation can be held in one location.
• No additional hardware required to implement.
• Dashboard reports on the status of sites and documents to easily identify missing or lagging information.
• Protect documents against unauthorized modification.
• Supports single or multiple file uploads with single screen metadata tagging.
• Centralized Documentation-Access from Anywhere.
• Resolve document issues faster.
• Ability to search documents in many ways.
• Dramatic Reduction in the need to print, scan, and store multiple copies in several locations.
• Link documents together to create a complete document package.
We have been serving eTMF customers since 2007.
Email now to schedule a demonstration and see how Clireo and Arivis can help you with your eTMF needs.
Tricia McQuarrie
Clinical Operations Manager tricia.mcquarrie@arivis.com
Arivis, Inc.
2198 E. Camelback Road
Phoenix, AZ 85016
Tel. 602-957-2150
www.m3.arivis.com
Essential Regulatory Documents in Clinical TrialsTrialJoin
The term ‘’essential documents’’ refers to the documents which, according to the ICH-GCP Guidelines, serve to evaluate the trial conducted, data quality and integrity. These documents are contained in the Trial Master File and are otherwise known as Regulatory Documents. Such documents are usually the important agreements, contracts, delegation logs, training logs, etc.
Maintaining and storing these essential regulatory documents is an important practice in clinical research. The proper filing and organization of these documents can greatly improve a clinical trial management. Usually, Regulatory Documents will be stored in a binder (or binders) that’s provided to the site for that specific study.
Filling out these documents and filing them properly is the site’s and especially the PI’s responsibility. Storing them properly is also the site’s responsibility, not the CRA’s. In any case, after the study is over, the sponsor or the CRO will inform the site if they should keep the originals or make copies of the Regulatory Documents for storage. Similarly, the sponsor or the CRO will also tell the site how long they need the documents to be kept and stored on-site.
Advance Information Management Through eTMF and CTMS ConvergenceWingspan Technology
With the increasing need for oversight of studies taking place across the globe, effective TMF management through an eTMF is just the tip of the iceberg for enhancing your organizations’ collaboration strategies. By utilizing an eTMF in conjunction with a CTMS, the opportunity to improve management of information is afforded.
A Trial Master File (TMF) is set up at the beginning of the trial. It is a collection of all essential documents pertaining to the trial, which in turn will allow for effective monitoring and supervision (audit). In order to demonstrate compliance with the applicable regulations, Good Clinical Practice (GCP) guidelines and the protocol – a well organised TMF is essential.
According to the GCP guidelines, it is the responsibility of the sponsor to ensure that the TMF includes all relevant essential documents, and is stored in a secure location, with restricted access. Generally, the TMF is maintained at the sponsor’s office, co-ordinating site or by the Contract Research Organisation (CRO), if contracted. In addition to the TMF, copies of all relevant documents must be kept at each participating site, in an Investigator Site File (ISF). The ISF will also include all site-specific essential documents. For example, site preparedness log or site visit logs, etc.
A member of the research or trial team should be delegated with the task of updating, maintaining and reviewing the TMF and ISF, periodically throughout the course of the clinical trial as per the defined SOPs. Ideally, the documents included in the TMF are:
Trial documents (protocol, investigator’s brochure, participant information documents, SOPs, instructions, manuals, guidelines, etc.)
Documents related to the Investigational Product (certificates of analysis, shipment records, storage records, etc.)
Training documentation for the trial team
Details of the laboratories, if applicable.
Contracts, agreements, budgets, etc.
Monitoring visit reports (for each site visit onsite or central)
Documents related to the safety reporting
Ethics Committees documents (composition of the EC, approvals, notifications, reports, etc.)
Site-specific documents (list of site staff and their curriculum vitae, investigator’s undertaking, site preparedness documents, training of site staff, etc.)
Audit related documents, if available (if an audit was conducted).
Significant communications
Others
The GCP guidelines provide comprehensive guidance regarding the documents to be included in a Trial Master File categorised according to the lifecycle of the trial. This information can also be accessed here.
It shall be the responsibility of the sponsor to make arrangements for the safe and secure custody of all study-related documents and material for a period of three years after the completion of the study or submission of the data to the regulatory authority(ies) whichever is later.
Six Elements of the QC Process.
To learn more about the QC Process join us for a complimentary webinar ( March 29 @11am EST) where we will follow a TMF document through its life cycle from creation through inspection: Learn how TMF documents should maneuver through TMF submissions and quality checks utilizing well-developed processes, tools and metrics to ensure the TMF is ready when the inspectors come knocking.
Presented by: Jackie Morrill - Director of Clinical Operations
Register Here: http://bit.ly/2kqA6s8
Since its release in 2010, The DIA’s TMF Reference Model has proven to be extremely valuable to the life sciences industry. In this content-packed webinar, we will provide a history and overview of the Model, present its structure, and the various sub-groups and resources available. The Model is not intended to be used “off-the-shelf" but can be implemented according to certain expectations and requirements of life science sponsors (pharma, bio, device), investigative sites (academic, for-profit, nonprofit) and CROs / third-party team members alike.
Paul Fenton, CEO of Montrium and CGI Life Science’s Fran Ross, both Members of the TMF Reference Model Steering Committee, will discuss strategies for implementing the Model and how it can be used to ensure tight controls of GxP required content for inspection. Finally, the session will present the TMF Reference Model Exchange Mechanism Standard which extends the Model's capability to facilitate eTMF interoperability and content exchange.
Using Vault eTMF Milestones and EDLs to Support Inspection ReadinessVeeva Systems
Hear how Daiichi Sankyo is using milestones and expected document lists (EDLs) to enable ongoing inspection readiness and proactive TMF management and oversight.
Essential Regulatory Documents in Clinical TrialsTrialJoin
The term ‘’essential documents’’ refers to the documents which, according to the ICH-GCP Guidelines, serve to evaluate the trial conducted, data quality and integrity. These documents are contained in the Trial Master File and are otherwise known as Regulatory Documents. Such documents are usually the important agreements, contracts, delegation logs, training logs, etc.
Maintaining and storing these essential regulatory documents is an important practice in clinical research. The proper filing and organization of these documents can greatly improve a clinical trial management. Usually, Regulatory Documents will be stored in a binder (or binders) that’s provided to the site for that specific study.
Filling out these documents and filing them properly is the site’s and especially the PI’s responsibility. Storing them properly is also the site’s responsibility, not the CRA’s. In any case, after the study is over, the sponsor or the CRO will inform the site if they should keep the originals or make copies of the Regulatory Documents for storage. Similarly, the sponsor or the CRO will also tell the site how long they need the documents to be kept and stored on-site.
Advance Information Management Through eTMF and CTMS ConvergenceWingspan Technology
With the increasing need for oversight of studies taking place across the globe, effective TMF management through an eTMF is just the tip of the iceberg for enhancing your organizations’ collaboration strategies. By utilizing an eTMF in conjunction with a CTMS, the opportunity to improve management of information is afforded.
A Trial Master File (TMF) is set up at the beginning of the trial. It is a collection of all essential documents pertaining to the trial, which in turn will allow for effective monitoring and supervision (audit). In order to demonstrate compliance with the applicable regulations, Good Clinical Practice (GCP) guidelines and the protocol – a well organised TMF is essential.
According to the GCP guidelines, it is the responsibility of the sponsor to ensure that the TMF includes all relevant essential documents, and is stored in a secure location, with restricted access. Generally, the TMF is maintained at the sponsor’s office, co-ordinating site or by the Contract Research Organisation (CRO), if contracted. In addition to the TMF, copies of all relevant documents must be kept at each participating site, in an Investigator Site File (ISF). The ISF will also include all site-specific essential documents. For example, site preparedness log or site visit logs, etc.
A member of the research or trial team should be delegated with the task of updating, maintaining and reviewing the TMF and ISF, periodically throughout the course of the clinical trial as per the defined SOPs. Ideally, the documents included in the TMF are:
Trial documents (protocol, investigator’s brochure, participant information documents, SOPs, instructions, manuals, guidelines, etc.)
Documents related to the Investigational Product (certificates of analysis, shipment records, storage records, etc.)
Training documentation for the trial team
Details of the laboratories, if applicable.
Contracts, agreements, budgets, etc.
Monitoring visit reports (for each site visit onsite or central)
Documents related to the safety reporting
Ethics Committees documents (composition of the EC, approvals, notifications, reports, etc.)
Site-specific documents (list of site staff and their curriculum vitae, investigator’s undertaking, site preparedness documents, training of site staff, etc.)
Audit related documents, if available (if an audit was conducted).
Significant communications
Others
The GCP guidelines provide comprehensive guidance regarding the documents to be included in a Trial Master File categorised according to the lifecycle of the trial. This information can also be accessed here.
It shall be the responsibility of the sponsor to make arrangements for the safe and secure custody of all study-related documents and material for a period of three years after the completion of the study or submission of the data to the regulatory authority(ies) whichever is later.
Six Elements of the QC Process.
To learn more about the QC Process join us for a complimentary webinar ( March 29 @11am EST) where we will follow a TMF document through its life cycle from creation through inspection: Learn how TMF documents should maneuver through TMF submissions and quality checks utilizing well-developed processes, tools and metrics to ensure the TMF is ready when the inspectors come knocking.
Presented by: Jackie Morrill - Director of Clinical Operations
Register Here: http://bit.ly/2kqA6s8
Since its release in 2010, The DIA’s TMF Reference Model has proven to be extremely valuable to the life sciences industry. In this content-packed webinar, we will provide a history and overview of the Model, present its structure, and the various sub-groups and resources available. The Model is not intended to be used “off-the-shelf" but can be implemented according to certain expectations and requirements of life science sponsors (pharma, bio, device), investigative sites (academic, for-profit, nonprofit) and CROs / third-party team members alike.
Paul Fenton, CEO of Montrium and CGI Life Science’s Fran Ross, both Members of the TMF Reference Model Steering Committee, will discuss strategies for implementing the Model and how it can be used to ensure tight controls of GxP required content for inspection. Finally, the session will present the TMF Reference Model Exchange Mechanism Standard which extends the Model's capability to facilitate eTMF interoperability and content exchange.
Using Vault eTMF Milestones and EDLs to Support Inspection ReadinessVeeva Systems
Hear how Daiichi Sankyo is using milestones and expected document lists (EDLs) to enable ongoing inspection readiness and proactive TMF management and oversight.
This presentation describes a case study of an eTMF structure, setup, and implementation at a biotechnology company currently conducting a pivotal Phase 3 clinical study in 70 centers worldwide.
Clinical Data Management Plan_Katalyst HLSKatalyst HLS
Introduction to Data Management Plan in Clinical Data Management in Clinical Trials of Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
A Trial Master File (TMF) is a comprehensive collection of essential documents and records that are generated or collected during the conduct of a clinical trial. The TMF serves as the centralized repository of all study-related documentation and provides a complete and accurate account of the trial's planning, execution, and outcomes. It is an important component of Good Clinical Practice (GCP) and regulatory compliance.
Appalla Venkataprabhakar and I presented this at the Oracle\'s Annual Clinical Development and Safety Conference 2010 at Hyderabad, India on 6th October 2010.
Adverse Events and Serious Adverse Events - Katalyst HLSKatalyst HLS
Introduction to Adverse Events & Serious Adverse Events in Pharmacovigilance and Drug Safety in Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Contact:
"Katalyst Healthcares & Life Sciences"
South Plainfield, NJ, USA
info@KatalystHLS.com
TSDP tells about the essential documents that are required for the #conduct of a clinical trial. For #regulatory medical writing training, contact hello@turacoz.in.
Integrating Clinical Operations and Clinical Data Management Through EDCwww.datatrak.com
When electronic data capture was first introduced there was a great deal of discussion surrounding how the technology would alter the roles of those in clinical operations and clinical data management. Through the review of a case study, we will explore how EDC is used as a tool to more tightly integrate clinical operational staffs with those in clinical data management resulting in a more streamlined process from study initiation to database lock.
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...Montrium
In this presentation, we explore the TMF fundamentals and an introduction to better managing your TMF. We'll start by diving into the world of TMF management, how to properly leverage the regulations, which documents constitute as TMF-worthy and what basic metrics you can track to increase the efficiency of your trial.
Finally, we will also discuss some of the features Montrium has developed to facilitate the management of the Trial Master File in a fundamental way.
This presentation covers the following topics:
-Fundamentals of TMF management process
-How to use the regulations to ensure success
-What cross functional groups hold TMF worthy documents
-TMF management challenges and how you can alleviate them
-Base metrics to track and what they mean to your organization
-How an eTMF helps TMF Management
You can follow along with this presentation via our webinar:
https://info.montrium.com/tmf-fundamentals-an-introduction-to-better-trial-master-file-management
Explaining the importance of a database lock in clinical researchTrialJoin
One of the most crucial aspects of research is clinical data management or CDM. Proper CDM will generate results with excellent quality, integrity, and reliability. Quality data is essential in order to support the final conclusions of a certain study.
The person responsible for this area of research is called a clinical data manager. This job position can be filled by a PI, a study coordinator, or a CRA. No matter who fills this position at your site, data management has to be done promptly and correctly in order to generate the best results. Aside from all the other reasons why data management is so important, it’s also what determines the future IP (investigational product) development.
Life science companies expect electronic trial master file (eTMF) projects to provide greater efficiency, improve quality, increase standardization and enhance collaboration in TMF management. Join Paragon Solutions for the second session of our TMF webinar series to gain insights on the practical factors to consider when planning a new or improved future state eTMF. We'll share industry data on eTMF drivers, and discuss our definition of a robust eTMF. You'll learn why TMF information architecture is so critical to eTMF uptake and usability, and high level considerations for systems integration/migration. Finally, we'll define the maturity framework that allows for assessment of eTMF organizational readiness, a critical baseline to successful future state eTMF planning.
DIA Reference Model a Guidance for Good Document Management and eTMFSagar Ghotekar
The TMF Reference Model is managed under the Drug Information Association (DIA) Document and Records Management Community. The TMF Reference Model Provides Standardized Taxonomy and Metadata & outlines a reference definition of TMF content using standard Nomenclature.
In this presentation, we explore the TMF fundamentals and an introduction to better managing your TMF. We'll start by diving into the world of TMF management, how to properly leverage the regulations, which documents constitute as TMF-worthy and what basic metrics you can track to increase the efficiency of your trial.
Finally, we will also discuss some of the features Montrium has developed to facilitate the management of the Trial Master File in a fundamental way.
This presentation covers the following topics:
-Fundamentals of TMF management process
-How to use the regulations to ensure success
-What cross functional groups hold TMF worthy documents
-TMF management challenges and how you can alleviate them
-Base metrics to track and what they mean to your organization
-How an eTMF helps TMF Management
You can follow along with this presentation via our webinar:
https://info.montrium.com/tmf-fundamentals-an-introduction-to-better-trial-master-file-management
This presentation describes a case study of an eTMF structure, setup, and implementation at a biotechnology company currently conducting a pivotal Phase 3 clinical study in 70 centers worldwide.
Clinical Data Management Plan_Katalyst HLSKatalyst HLS
Introduction to Data Management Plan in Clinical Data Management in Clinical Trials of Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
A Trial Master File (TMF) is a comprehensive collection of essential documents and records that are generated or collected during the conduct of a clinical trial. The TMF serves as the centralized repository of all study-related documentation and provides a complete and accurate account of the trial's planning, execution, and outcomes. It is an important component of Good Clinical Practice (GCP) and regulatory compliance.
Appalla Venkataprabhakar and I presented this at the Oracle\'s Annual Clinical Development and Safety Conference 2010 at Hyderabad, India on 6th October 2010.
Adverse Events and Serious Adverse Events - Katalyst HLSKatalyst HLS
Introduction to Adverse Events & Serious Adverse Events in Pharmacovigilance and Drug Safety in Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Contact:
"Katalyst Healthcares & Life Sciences"
South Plainfield, NJ, USA
info@KatalystHLS.com
TSDP tells about the essential documents that are required for the #conduct of a clinical trial. For #regulatory medical writing training, contact hello@turacoz.in.
Integrating Clinical Operations and Clinical Data Management Through EDCwww.datatrak.com
When electronic data capture was first introduced there was a great deal of discussion surrounding how the technology would alter the roles of those in clinical operations and clinical data management. Through the review of a case study, we will explore how EDC is used as a tool to more tightly integrate clinical operational staffs with those in clinical data management resulting in a more streamlined process from study initiation to database lock.
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...Montrium
In this presentation, we explore the TMF fundamentals and an introduction to better managing your TMF. We'll start by diving into the world of TMF management, how to properly leverage the regulations, which documents constitute as TMF-worthy and what basic metrics you can track to increase the efficiency of your trial.
Finally, we will also discuss some of the features Montrium has developed to facilitate the management of the Trial Master File in a fundamental way.
This presentation covers the following topics:
-Fundamentals of TMF management process
-How to use the regulations to ensure success
-What cross functional groups hold TMF worthy documents
-TMF management challenges and how you can alleviate them
-Base metrics to track and what they mean to your organization
-How an eTMF helps TMF Management
You can follow along with this presentation via our webinar:
https://info.montrium.com/tmf-fundamentals-an-introduction-to-better-trial-master-file-management
Explaining the importance of a database lock in clinical researchTrialJoin
One of the most crucial aspects of research is clinical data management or CDM. Proper CDM will generate results with excellent quality, integrity, and reliability. Quality data is essential in order to support the final conclusions of a certain study.
The person responsible for this area of research is called a clinical data manager. This job position can be filled by a PI, a study coordinator, or a CRA. No matter who fills this position at your site, data management has to be done promptly and correctly in order to generate the best results. Aside from all the other reasons why data management is so important, it’s also what determines the future IP (investigational product) development.
Life science companies expect electronic trial master file (eTMF) projects to provide greater efficiency, improve quality, increase standardization and enhance collaboration in TMF management. Join Paragon Solutions for the second session of our TMF webinar series to gain insights on the practical factors to consider when planning a new or improved future state eTMF. We'll share industry data on eTMF drivers, and discuss our definition of a robust eTMF. You'll learn why TMF information architecture is so critical to eTMF uptake and usability, and high level considerations for systems integration/migration. Finally, we'll define the maturity framework that allows for assessment of eTMF organizational readiness, a critical baseline to successful future state eTMF planning.
DIA Reference Model a Guidance for Good Document Management and eTMFSagar Ghotekar
The TMF Reference Model is managed under the Drug Information Association (DIA) Document and Records Management Community. The TMF Reference Model Provides Standardized Taxonomy and Metadata & outlines a reference definition of TMF content using standard Nomenclature.
In this presentation, we explore the TMF fundamentals and an introduction to better managing your TMF. We'll start by diving into the world of TMF management, how to properly leverage the regulations, which documents constitute as TMF-worthy and what basic metrics you can track to increase the efficiency of your trial.
Finally, we will also discuss some of the features Montrium has developed to facilitate the management of the Trial Master File in a fundamental way.
This presentation covers the following topics:
-Fundamentals of TMF management process
-How to use the regulations to ensure success
-What cross functional groups hold TMF worthy documents
-TMF management challenges and how you can alleviate them
-Base metrics to track and what they mean to your organization
-How an eTMF helps TMF Management
You can follow along with this presentation via our webinar:
https://info.montrium.com/tmf-fundamentals-an-introduction-to-better-trial-master-file-management
DevOps for Highly Regulated EnvironmentsDevOps.com
Financial institutions, medical groups, governmental organizations, automotive companies… these types of entities all have unique and sometimes difficult-to-meet regulations. You may be required to have fine-grained auditability of your SDLC or maintain specific third-party integrations. Security models may be heightened, or certain types of compliance processes maintained. So how are we supposed to “do the DevOps” when we have so many things to worry about? In this webinar, we’ll explore some ways that you can adopt DevOps best practices and even (gasp!) thrive when building your DevOps and DevSecOps pipelines in highly-regulated industries.
Covance, in partnership with Oracle, offers a full-service, validated, private cloud, single-tenancy solution based on Argus technology, which enables faster and better safety decisions. This automated and integrated solution allows for easy scientific querying and analytics, which improves the quality and efficiency of safety operations. It also enhances compliance with E2B exchange for expedited and periodic reporting, allowing the organization to conduct global case processing, which can scale to tens of thousands of annual cases.
Webinar presentation September 20, 2016.
This deck introduces the CSCC’s deliverable, Cloud Security Standards: What to Expect and What to Negotiate V2.0, which was updated in August 2016 to reflect the latest developments in cloud security standards. The presentation is an overview of the various security standards, frameworks, and certifications that exist for cloud computing. This information will help cloud customers understand and distinguish between the different types of security standards that exist and assess the security standards support of their cloud service providers.
Read the CSCC's deliverable here: http://www.cloud-council.org/deliverables/cloud-security-standards-what-to-expect-and-what-to-negotiate.htm
In a unified eClinical infrastructure, formerly disparate clinical study systems are merged.
Users no longer work in “CTMS” or “eTMF”, but in a harmonized clinical infrastructure where a single source of truth is a given, and changes and additions automatically impact the appropriate data, documents and processes.
This presentation will show you what clinical unification is, its benefits and how it can be achieved.
Document Management and Digitization solutions for medium sized EnterprisesTeamBreota
How to simply document management. The presentation describes document management and digitization solutions for medium sizes businesses and small businesses.
Webinar presentation: November 17, 2016
Subject matter experts from the CSCC present an overview of the security standards, frameworks, and certifications that exist for cloud computing. We also discuss privacy considerations in light of new regulations (e.g., EU’s General Data Protection Regulation (GDPR)). This presentation helps cloud customers understand and distinguish between the different types of security standards that exist and assess the security standards support of their cloud service providers.
Read the CSCC's deliverable, Cloud Security Standards: What to Expect and What to Negotiate: http://www.cloud-council.org/deliverables/cloud-security-standards-what-to-expect-and-what-to-negotiate.htm
AWS re:Invent 2016: Common Considerations for Data Integrity Controls in Heal...Amazon Web Services
This session is intended for customers seeking to build out a comprehensive plan around data integrity in the cloud. Information governance, system validation, PHI and PII records come with their own set of regulatory considerations - and by using tools such as AWS CloudFormation, Amazon Virtual Private Cloud, Directory Service, AWS SDKs, RDS, AWS CloudTrail, and Amazon CloudWatch portions of the governance burden can be lifted, offloaded, or partnered around. A look at the top ten data integrity controls will be considered, including a customer presentation featuring an example of a regulated quality management system. Finally, the physical import/export tool Snowball's addition to the AWS Business Associate Agreement (BAA) program will be discussed, along with the practical application and security implications of chain of custody.
Improve Clinical Trial Processes With a Unified PlatformVeeva Systems
Veeva and Idorsia share how your organization can leverage a unified clinical operating model and drive new levels of efficiency across the entire clinical ecosystem.
10 Things to Consider When Building a CTMS Business CasePerficient, Inc.
Sponsors and research organizations are often tasked with building a business case for a clinical trial management system (CTMS) before they even evaluate the various solutions in the marketplace.
After multiple successful Oracle Siebel CTMS implementations, Perficient has identified 10 ways you can benefit from a CTMS solution.
In this slideshare we share information that you can leverage as you develop a business case for a CTMS.
We also demonstrate the two most popular CTMS benefits and corresponding features.
RegDocs365. Regulated content for life scienceBelloMen
RegDocs365 is a best-of-breed, regulated content and document management solution for life science companies hosted in an Audit
Ready Compliant Cloud™ (ARCC) validated environment.
Pharma, biotech, CROs and vendors can easily streamline workflows in an FDA 21 CFR Part 11 compliant environment at any stage of drug development through commercialization - including discovery, clinical trials, regulatory submissions, and post market.
Diaspark healthcare offers software product development, compliance implementation and mobility services to healthcare software vendors (EMR/EHR/HIE/HIS/ Home Healthcare), life science companies and non-profits. Right from developing key EHR software modules spanning CPOE, Patient Portals, eRX(ePrescription), eMAR, Clinical DSS, labs to building healthcare mobile apps over iOS, Android, Blackberry that even interact with health devices, we work as an extended enterprise to software product vendors and life science companies.
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceGreenlight Guru
Understand the FDA's new draft guidance on Computer Software Assurance (CSA).
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
2. Who is Arivis?
Arivis has been providing regulatory and clinical infrastructure since 2005
Many Firsts
• First cloud-based Regulatory Document Management System
• First cloud-based Regulatory Submission Management System
• First ever integrated Document, Project, and Submission Management
System
• First ever regulatory content planning system
• First ever cloud-based regulatory platform
• First Part 11 compliant solution in the cloud (since 2005)
• Solution used on every continent and virtually every country
The leader in Regulatory Information Management (RIM)
Offices in US (Phoenix) and Germany (Munich Area)
Garter recognized SaaS provider for FDA Regulated Industries
Arivis, Inc., Confidential
3. US Headquarters
Phoenix AZ
Global Headquarters
Munich Germany
Development Center
Rostok Germany
Global Organization
Arivis, Inc., Confidential
5. What you do is incredibly important. It is also very
challenging.
Arivis, Inc., Confidential
6. That is why you need ONE, easy-to-use cloud-based
system for one and all of your users needs.
Arivis, Inc., Confidential
7. That is why Arivis has introduced Clireo to support
Clinical eTMF
Commercial eMPM
Regulatory eDMS
Regulatory Submissions eCTD (+)
With secure, global access with single sign-on. Across
all of your internal and external users.
Arivis, Inc., Confidential
8. And we have been doing this a while. Our 21 CFR Part 11
cloud technology has been serving clients since 2007.
Arivis, Inc., Confidential
9. eDMS
Electronic
Document
Management
eTMF
Electronic Trial
Master File
VDR
Virtual Data
Room
PM
Project
Management
Submission
s
eCTD & Paper
Regulatory
Submissions
eMPM
Electronic
Management of
Promotional
Materials
Part 11
Compliant
Audit Trail
User
Configurable
Administratio
n
Claims-based
authentication
supporting
AzureAD, AD,
Windows Live
Bulk
Document
Handling
Functionality
Role Based,
Group &
Individual
Security
Digital and
Electronic
Signature
Support
Platform &
Web-browser
Independent
Lucene
Search and
Global
Access
Project
rather than
user based
licensing
Over 300
regulatory
templates in
Word and
XML.
Configurable
storage and
support for
eDMS and
eTMF models
Versioning,
Check-in /
out,
Signatures,
Renditions,
Context
Metadata
Web-based
component
authoring
Workflow
and
Notifications
Secure web-
browser
viewing
Graphical
and
Exportable
Reporting
HIPAA
compliant
BAA
Multiple
geographic
copies
Software &
Hardware
monitoring
NSProtect
Security
Independently
audited facilities
and equipment
CFR 21
Part 11
Compliance
Security
Best
Practices
Upgrade on
demand
Flexible and
unlimited data
storage with 6x data
replication
11. What is a TMF?
Traditionally kept as a set of binders, the Trial Master
File (TMF) includes an array of document types
ranging from Site Contracts to Clinical Study Reports
with numerous documents of each type, often
resulting in a total collection of thousands of
documents in each TMF.
“These documents serve to demonstrate the
compliance of the investigator, sponsor and monitor
with the standards of Good Clinical Practice and with
all applicable regulatory requirements.” – ICH GCP E6
(R1)
Arivis, Inc., Confidential
12. Essential Documents
Documents which individually and collectively
permit evaluation of the conduct of a trial and
quality of the data produced
Usually the documents are audited by the
sponsor’s independent audit function and
inspected by Health Authorities as part of the
process to confirm the validity of the trial
conduct and the integrity of the data collected.
Arivis, Inc., Confidential
13. Pre-site selection
• Investigators Brochure
• Protocol
• Informed consent
• CRF
Site Selection
• Confidentiality agreement
• Pre-study visit (investigator
selection,site suitability,items
concerning overall study
conduct)
Regulatory
• Notification of IND # or CTA
approval
• Registration in Clinicaltrials.gov
• IRB/IEC Submission
Site Set-up
• Protocol signature page
• PI & Sub-I cv
• Form FDA 1572
• Financial Disclosure
Monitoring
• Trial initiation monitoring report
• Site training documentation
• Monitoring visit report
• Protocol deviations
Investigational
Product
• Instructions for handling
• Accountability Documentation
Safety
• Safety Management plan
• SAE reports
• Pharmacovigilance Database
Line Listing
Centralized Testing
Facility
• Normal ranges
• Certificate of accreditation
Third party
Oversight
• Confidentiality Agreement
• Contractual Agreement
Data Management
• Data Mgmt. Plan
• CRFs
• EDC
Statistical Analysis
• SAP
• Randomization Plan
• Datasets
• Programs
Clinical Study
Report
Essential Documents Collected
During a Clinical Trial
Arivis, Inc., Confidential
14. Challenges
The Life Science industry is facing pressure to cut costs while facing
increasingly challenging regulatory requirements- which have increased the
cost.
With more clinical studies being conducted globally, paper TMFs are becoming
more of a challenge as file numbers increase.
Arivis, Inc., Confidential
15. What is an eTMF System?
An eTMF system is the application of a 21 CFR 11 compliant electronic
document management system to automate time consuming error-prone
manual paper-based processes.
Documents and content are stored centrally on a computer server “cloud”
versus in binders.
Secure internet connection that can be accessed globally with auditable
security
Arivis, Inc., Confidential
17. eTMF Cost Savings
Item N Frequency Unit Cost Total Year 1 Total Year 2 Total Cost for 2 Years
Electronic TMF
Setup and implementation 1 1 $ 20,000.00 $ 20,000.00 $ - $ 20,000.00
Software License and hosting 1 12 $ 2,400.00 $ 28,800.00 $ 28,800.00 $ 57,600.00
Personnel .5 FTE 1040 $ 20.00 $ 20,800.00 $ 20,800.00 $ 41,600.00
Yearly Total $ 48,800.00 $ 18,000.00
Total Cost of eTMF for 2 Years $ 119,200.00
Paper TMF
CRO/Sponsor Document Transfers
(200 documents per month)
40 40 $ 50.00 $ 80,000.00 $ 80,000.00 $ 160,000.00
Fire Proof Filing Cabinets 15 1 $ 2,000.00 $ 30,000.00 $ - $ 30,000.00
Off-site Storage (7 years) 12 7 $ 75.00 $ 6,300.00 $ - $ 4,500.00
Personnel 1 FTE 2080 $ 20.00 $ 41,600.00 $ 41,600.00 $ 83,200.00
Yearly Total $ 157,900.00 $ 121,600.00
Total Cost of Paper TMF for 2 Years $ 277,700.00
Total amount saved $ 158,500.00
Return On Investment 154%
Arivis, Inc., Confidential
18. Benefits of Applying the DIA
Reference Model to TMF
Trial master files should be established at the
beginning of the trial, both at the
investigator/institution’s site and at the sponsor’s
office.
A final close-out of a trial can only be done when
the monitor has reviewed both
investigator/institution and sponsor files and
confirmed that all necessary documents are in the
appropriate files.
Arivis, Inc., Confidential
19. Flexible and unlimited
data storage with 6x data
replication
Project Management
Project rather
than user
based
licensing
Support for
Industry
Standards
Version
Control
(Check-in/out)
Complex
Metadata
Workflow and
Notifications
Email
Document Link
View
Documents in
Web-browser
Easy
Administration
Bulk Upload
Role Based
Permissions
Quick and
Simple
Configuration
and Start-up
Google-like
Search
Document
Storage &
Classification
Search,
retrieval &
distribution
Authoring &
review,
collaboration
Global
availability 24/7
Single sign-on
21-CFR-Part 11
compliant
Standard but
customizable
hierarchy
Metrics and
Reporting
VDR
• Business
Development
EDMS
• Regulatory,
Nonclinical, CMC
eTMF
• Clinical Trial
Documents
Submissions
• Regulatory Submissions
in eCTD format
eMPM
• Post-
marketing
Multiple
copies across
the globe
NSProtect
Security
HIPAA
Compliant
BAA
Open API
Software and
hardware
monitoring
Upgrade on
demand
Claims-based
authentication
Document
Encryption
Services
Arivis, Inc., Confidential
20. What is Clireo?
Clireo is: Electronic Document Management
• Compliant with the DIA EDM Reference Model and ad hoc models
• Context Sensitive Metadata
• Automated PDF Renditions
• Digital and Electronic Submissions
• Part 11 Compliance
Clireo is: Electronic (eCTD, NEES) and Paper (510k, PMA) Submission
• Comprehensive submission management and tracking system
• Globally compliant
• Support for IND, NDA, MAA, BLA, 510k, PMA to name a few
Clireo is: Electronic Trial Master File
• Comprehensive Software and Service enabling the Trial Master File
• Compliant with the DIA Trial Master File Reference Model
Arivis, Inc., Confidential
21. What is Clireo?
Clireo is: Project Management and Planning
• Complete project management
• Automated rollup of document completeness
Clireo is: Virtual Data Room
Clireo is: Component Authoring
Clireo is: Comprehensive Reporting
• Mobile iOS application for tracking project status in real-time
• Comprehensive document, project, clinical and regulatory reports
• Export in multiple formats
Clireo is: Regulatory Tracking
Arivis, Inc., Confidential
22. How can Clireo eTMF help
me?
Assign access and
maintain control of
Sites, Vendors, and
Auditors for content.
Eliminate CRA need to
reconcile the
Investigator Site File
against the Sponsor
TMF.
Part 21 CFR 11 Digital
signatures allow for
faster turn around
time on documents.
Ability to disseminate
new information to
users that the
information is
relevant to.
Vendors and Sites can
upload documentation
and data directly into
Clireo.
Unlimited storage
capacity assures that
all documentation can
be held in one
location.
Arivis, Inc., Confidential
23. How can Clireo eTMF help
me?
No additional hardware
required to implement
Dashboard reports on the
status of sites and documents
to easily identify missing or
lagging information.
Protect documents against
unauthorized modification.
Supports single or multiple
file uploads with single
screen metadata tagging.
Centralized Documentation-Access
from Anywhere.
Resolve document issues faster.
Ability to search documents in
many ways.
Dramatic Reduction in the need to
print, scan, and store multiple
copies in several locations.
Link documents together to create
a complete document package.
Arivis, Inc., Confidential
24. The integrated HTML
5 viewer securely
lets users view
document content
on any platform or
browser
View Documents
Anywhere…on Any Device
Arivis, Inc., Confidential
25. Site eTMF must be under
the control of the PI while
secure and selective
access granted to the
sponsor.
The sponsor eTMF is under
the sponsors control.
Single Sign-On into your own
System and Partner’s Systems
Arivis, Inc., Confidential
26. Clireo Document Management
Clireo offers brilliant end-user functionality
In addition, Clireo offers a set of advanced back-end tools to support advanced
business processes:
• Bulk loading of documents and all other file types
• Bulk loading of electronic submissions
• Bulk loading of submissions + their associated documents simultaneously
• Automated / on-going document loading from FTP and sFTP sites
• Comparison of documents classified vs documents still in holding zone
• Bulk document / data extraction and download
• Project deployment using Microsoft Project files honoring all dates, structures, and
relationships
Arivis, Inc., Confidential
27. eTMF – your Clinical
Document Source
Staging area and support for FTP document transmittal
eTMF specific reporting
DIA eTMF Reference Model Support both in hierarchy and metadata
Global Access
Inspector Portal
cGCP compliant access and ownership for site documents
Placeholder documents with expected dates
eTMF specific workflows and statuses
Arivis, Inc., Confidential
28. Rich Document Management
Features
Workflow (parallel and
sequential)
Electronic Signatures
PDF Rendering
Digital signatures
Document cross linking
Document relationships
tracking
Project Management
Collaborative Review
Version and document
compare
Version control
Library services
Viewing without
downloading (HTML5)
Detailed permissions and
group support
Context sensitive
metadata
Arivis, Inc., Confidential
29. We have found
that users want
better oversight,
better control,
and more
functionality.
Clireo lets you
do more in one
screen than
other
applications
Do More in One Screen
Arivis, Inc., Confidential
30. Dynamic quick views
of always on
information. Plus deep
drill down with
comprehensive
industry and
application specific
reports
Better Insight: Actionable
Information at your Fingertips
Arivis, Inc., Confidential
31. Everyone can be given access.
Your eTMF documents can link to
your eDMS, and your eDMS
document can link to your
submission.
Eliminating Boundaries across
Companies and Departments
Arivis, Inc., Confidential
32. Workflows, project
structures, reference
models, metadata, and
product features working
together to support eTMF,
eCTD, eDMS, eMPM, and
VDR yet an application
flexible enough to support
all of your needs.
Support for Specific Life
Science Business Processes
Arivis, Inc., Confidential
33. Arivis Professional Services
The Professional Services Group at Arivis provides premier strategic and tactical
services to fit your specific regulatory needs with individual attention to detail.
The continuum of bringing a Life Science product from concept to market is a long,
complex endeavor which requires many experts in a variety of fields. During the
journey, years’ worth of data and documents are created. Coordinating all of the
stages, resources, and information is critical during the process. Keeping an eye on
all of the moving parts in an ever more complicated world is even more critical for
decision makers.
Arivis has the expertise and solutions that meet the needs of Pharmaceutical,
Medical Device, Biotech, Combination Product and Diagnostics companies,
regardless of your size or state of your business. Our team provides complete
regulatory information management and tracking solutions to manage your product
information worldwide. The end result is a seamless process through the whole life
cycle of your projects.
Arivis, Inc., Confidential
34. Arivis Professional Services
Collaboration is the key to our success. From initial project
initiation and throughout the engagement, we bond with our
clients and work together to reach strategic objectives.
We will share our knowledge, guide you through the complicated
regulatory landscape and provide skill-building assistance to help
you become self-sufficient at managing your projects.
Arivis, Inc., Confidential
35. Arivis Professional Services
Do you currently maintain paper trial master files
(TMF)? Do you have an unsecured shared drive
containing important Regulatory documentation?
Arivis Professional Services Group can help you
prepare and organize documents to be used in due
diligence activities, regulatory submissions, and
Quality Assurance inspections/audits. We can help
you to scan, index, and archive documents utilizing
industry best practices and reference models. We
have extensive experience in clinical electronic
trial master files and document management
systems and can host these cloud-based systems for
you so you and your team can have access 24/7.
Arivis Professional Services Group, enabled by best-
in-class technologies, enable simplified document
management and maintenance.Arivis, Inc., Confidential
36. Experience
Execution is the name of the game and it is achieved through action.
The Arivis Professional Services Group has recognized expertise in integrating
compliance, business processes, and technology into innovative and practical
IT solutions for Regulatory submissions to global health authorities and
maintains deep knowledge and understanding of the submission process and
regulatory requirements.
Arivis, Inc., Confidential
37. Quality
Achieving service excellence is one of our main goals at Arivis. We pride
ourselves on maintaining a Professional Services Quality Management System
that helps us to achieve consistent business processes and drive measurable,
cost-saving performance improvements.
The quality management system not only provides a structure and framework,
it also ensures security as well as an audit mechanism that enforces corrective
action. Continuous improvement happens within all processes in a systematic
manner.
Arivis, Inc., Confidential
38. Responsiveness
You've seen it, felt it, and experienced it: the pace of your business has
accelerated.
You're being asked to do more with less.
You're experiencing more budget pressures, more regulatory pressures, and more
competitive pressures.
If only you could turn to a business partner for innovative solutions to all of these
challenges. If only Regulatory Operations and Project Management professionals
were available whenever you need them.
Well, you can and they are!
When you're feeling the strain of limited resources, immediate assistance is just a
phone call or an e-mail away. We're here, ready and waiting to help you.
We understand the constraints you're under. After all, we were once in your shoes.
That's right: before joining Arivis we were clients ourselves. Largely as a result of
our experiences, we feel compelled to respond to your requests quickly and
efficiently. Upon receiving your request, we immediately set to work finding
solutions. We are committed to our clients’ success and respond accordingly. You
will have dedicated support where and when you need it.
Arivis, Inc., Confidential
39. Arivis Professional Services
Members of the PSG hale from various life science companies including Bristol Myers-
Squibb, Eli Lilly, Celgene, Cell Therapeutics Inc., C.R. Bard, Medicis, and ImClone
Systems.
We were once in your shoes and feel compelled to respond to your requests quickly
and efficiently.
Provides premier
strategic and tactical
services to fit your
specific regulatory
needs.
The Arivis PSG live
and breath quality,
flexibility, and
responsiveness.
Arivis, Inc., Confidential
40. What We Do
eCTD Quality process definition, implementation, and documentation
Training
eCTD
• Publishing and Compilation
• Planning & Management
• eCTD strategy
• Publishing guides and project rules
• Define, interpret, and communicate Regulatory submission requirements
eTMF and eDMS
• Design and implementation
• Scanning, indexing, and archiving
• Templates, style guides
Arivis, Inc., Confidential
41. Arivis eTMF Professional
Services
Optional eTMF Professional Services in addition
to your software include:
Document Scanning / Conversion Services
eTMF Reference Model Classification and Organization Services
Ongoing eTMF Management Capabilities
Customer Support for Clinical Process Implementation
Complete eTMF Trial Management
Arivis, Inc., Confidential
42. Thank You
Clireo eTMF Demo
www.m3.arivis.com
Tricia McQuarrie
Tricia.McQuarrie@arivis.com
Clinical Operations Manager
Arivis, Inc.